p16 and retinoblastoma protein expression in endometrial carcinoma and clinical significance

European Journal of Gynaecological Oncology

Volumn 32, Issue 3, 2011, Pages 309-315

  Mue Koh, V ^a   Shi, Y X ^b   Tang, Q H ^b  

^a UNIVERSITY OF DOUALA   (Cameroon)

^b WUHAN UNIVERSITY   (China)

Author keywords

Endometrial carcinoma; Immunohistochemistry; p16 protein; Polymerase chain reaction; Retinoblastoma protein

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; POLYCLONAL ANTIBODY; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CARCINOGENESIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; HISTOCHEMISTRY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; TUMOR CELL;

ADENOCARCINOMA; ADULT; AGED; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RETINOBLASTOMA PROTEIN;

EID: 79960275577     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aagaard L., Lukas J., Bartkova J., Kjerulff A.A., Strauss M., Bastek J.: "Aberrations of p16INK4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines". Int. J. Cancer, 1995, 61, 115.
2. Serrano M., Hannon G.J., Beach D.: "A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4". Nature, 1993, 366, 704.
3. Li Nan et al.: "p16 gene and cancer". Foreign Med. Sci. (Cancer Section), 1995, 22, 257.
4. Fujino T., Risinger J.I., Collins N.K., Liu F.S., Nishii H., Takahashi H. et al.: "Allelotype of endometrial cancer". Cancer Res., 1994, 54, 4294.
5. Jen J., Harper J.W., Bigner S.H., Bigner D.D., Papadopoulos N., Markowitz S. et al.: "Deletion of p16 and p15 genes in brain tumors". Cancer Res., 1994, 54, 6353.
6. Xu M.H., Zhang Z.G., Lu Q.: "p16 protein histochemical assessment and clinical significance in endometrial cancer" (Xian Dai Fu Chan Ke Jin Zhan). J. Prog. Obstet. Gynaecol, 1997, 6, 320.
7. Sonoda Y., Yoshimoto T., Sekiya T.: "Homozygous deletion of MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma". Oncogene, 1995, 1843.
8. Shultz D.C., Vanderveer L., Buetow K.H., Boente M.P., Ozois R.F., Hamilton T.C., Godwin A.K.: "Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p including CDKN2". Cancer Res., 1995, 55, 153.
9. Walker D.G., Duan W., Popovic E.A., Kaye A.H., Tomlinson F.H., Lavin M.: "Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas". Cancer Res., 1995, 55, 20.
10. Fu G., Lü C.L.: "p16 and p15 gene deletion and leukemia". Foreign Med. Sci. (Cancer Section), 1997, 1, 52.
11. Lu Y.Y., Gao C.F., Cui J.T.: "Research on MTS1/p16 gene deletion and abnormal expression in stomach carcinoma". Chinese J. Cancer, 1996, 18, 189.
12. Devlin J., Elder P.A., Gabra H., Steel C.M., Knowles M.A.: "High frequency of chromosome 9 deletion in ovarian cancer". Br. J. Cancer, 1996, 73, 420.
13. Hatta Y., Hirama T., Takeuchi S., Lee E., Pham E., Miller C.W. et al.: "Alterations of the p16 gene in testicular, ovarian and endometrial malignancies". J. Urol., 1995, 154, 1954.
14. Peiffer S.L., Bartsch D., Whelan A.J., Mutch D.G., Herzog T.J., Goodfellow P.J.: "Low frequency of CDKN2 mutation in endometrial carcinoma". Mol Carcinog., 1995, 13, 210.
15. Zhou C.X., Sun J.H., Lu S.X., Liu H.L., Su T., Jin S.Q., Sheng X.: "Research on MTS1/p16 gene deletion in endometrial cancer". Chinese J. Cancer, 1997, 19, 404.
16. Huang Q., Tao Y.H., Li C.Y.: "Research on the aspect of p16, p15 gene in multiple primary malignant tumor cell line". Chinese J. Med. Genet., 1995, 13, 198.
17. Marx J.: "New tumor suppressor may rival p53". Science, 1994, 264, 344.
18. Mori T., Miura K., Aoki T., Nishihira T., Mori S., Nakamura Y.: "Frequent somatic mutation of the MTS1/CDK4 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell cancer". Cancer Res., 1994, 3396.
19. Nagakawa K., Conrad N.K., Williams J.P., Johnson B.E. Kelley M.J.: "Mechanism of inactivation of CDKN2 and MTS2 in non small cell lung cancer and associated with and vanced stage". Oncogene, 1995, 11, 1843.
20. Counts J.L., Goodman J.I.: "Alterations in DNA methylation may play a variety of role in carcinogenesis". Cell, 1995, 83, 13.
21. rd, Jones P.A.: "DNA methylation and cancer". Exs., 1993, 64, 487.
22. INK4 transcript". Cancer Res., 1995, 2995.
23. Bird A.P.: "CpG-rich islands and function of DNA methylation". Nature, 1986, 321, 209.
24. Eden S., Cedar H.: "Role of DNA methylation in the regulation of transcription". Curr. Opin. Genet. Dev., 1994, 4, 225.
25. Sun Y., Hildesheim A., Lanier A.E., Cao Y., Yao K.T., Raab-Traub N., Yang C.S.: "No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinoma". Oncogene, 1995, 10, 785.
26. st edition, New York, Springer-Verlag, 1977.
27. Pettersson W.F., Adami H.O., Lingren A., Hesseliu I.: "Endometrial polyps and hyperplasia as risk factors for endometrial cancer". Acta. Obstet. Gynecol. Scand., 1985, 64, 653.
28. Mayol X., Garriga J., Grana X.: "Cell cycle dependent phosphorylation of RB related protein 130". Oncogene, 1995, 11, 801.
29. Ambros R.A., Vigna P.A., Figge J., Kallakury B.V., Mastrangelo A., Eastman A.Y. et al.: "Observations on tumor metastatic suppressor gene status in human endometrial carcinoma with particular emphasis on p53". Cancer, 1994, 73, 1686.
30. Shapiro G.I., Park J.E., Edwards C.D., Mao L., Merlo A., Sidransky D. et al.: "Multiple mechanisms of p16INK4A inactivation in non small cell lung cancer cell hines". Cancer Res., 1995, 55, 6200.
31. Bartkova J., Lukas J., Guldberg P., Alsner J., Kirkin A.F., Zeuthen J., Bartek J.: "The p16-cyclin D/CdK4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis". Cancer Res., 1996, 56, 5475.
32. Kratzke R.A., Greatens T.M., Rubins J.B., Maddaus M.A., Niewoehner D.E., Niehans G.A., Geradts J.: "Rb and p16INK4A expression in resected non-small cell lung tumors". Cancer Res., 1996, 56, 3415.
33. Tam S.W., Shay J.W., Pagano M.: "Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitors p16INK4". Cancer Res., 1994, 54, 5816.
34. Serrano M., Hannon G.J., Beach D.: "A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4". Nature, 1993, 566, 704.